硝酸甘油对继发性雷诺现象中血管痉挛的客观缓解作用。
Objective relief of vasospasm by glyceryl trinitrate in secondary Raynaud's phenomenon.
作者信息
Coppock J S, Hardman J M, Bacon P A, Woods K L, Kendall M J
出版信息
Postgrad Med J. 1986 Jan;62(723):15-8. doi: 10.1136/pgmj.62.723.15.
Abstract
An objective response to topical glyceryl trinitrate was shown by digital plethysmography in a study of 17 patients with Raynaud's phenomenon. Improvement was significant (P less than 0.005) in those in whom the disease was secondary to an underlying connective tissue disorder. The response suggests that the effect of this drug is mediated locally.
摘要
在一项针对17例雷诺现象患者的研究中，通过数字体积描记法显示了对局部应用硝酸甘油的客观反应。在疾病继发于潜在结缔组织疾病的患者中，改善情况显著（P<0.005）。该反应表明这种药物的作用是局部介导的。
相似文献
1
Objective relief of vasospasm by glyceryl trinitrate in secondary Raynaud's phenomenon.硝酸甘油对继发性雷诺现象中血管痉挛的客观缓解作用。
Postgrad Med J. 1986 Jan;62(723):15-8. doi: 10.1136/pgmj.62.723.15.
2
Topical glyceryl trinitrate as adjunctive treatment in Raynaud's disease.局部用硝酸甘油作为雷诺病的辅助治疗
Lancet. 1982 Jan 9;1(8263):76-7. doi: 10.1016/s0140-6736(82)90215-x.
3
Sustained-release transdermal glyceryl trinitrate patches as a treatment for primary and secondary Raynaud's phenomenon.缓释硝酸甘油透皮贴剂治疗原发性和继发性雷诺现象
Br J Rheumatol. 1995 Jul;34(7):636-41. doi: 10.1093/rheumatology/34.7.636.
4
Topical nitroglycerin ointment in Raynaud's phenomenon.局部用硝酸甘油软膏治疗雷诺现象。
Z Kardiol. 1985 May;74(5):298-302.
5
Role of digital artery adrenoceptors in Raynaud's disease.数字动脉肾上腺素能受体在雷诺病中的作用。
Vasc Med. 1997;2(1):1-7. doi: 10.1177/1358863X9700200101.
6
Nicardipine in the treatment of Raynaud's phenomenon. Dissociation of platelet activation from vasospasm.尼卡地平治疗雷诺现象。血小板活化与血管痉挛的分离。
Arthritis Rheum. 1987 Mar;30(3):281-6. doi: 10.1002/art.1780300306.
7
[How I treat...Raynaud's phenomenon].[我如何治疗……雷诺现象]
Rev Med Liege. 1998 Mar;53(3):119-20.
8
Fish-oil dietary supplementation in patients with Raynaud's phenomenon: a double-blind, controlled, prospective study.雷诺现象患者补充鱼油膳食：一项双盲、对照、前瞻性研究。
Am J Med. 1989 Feb;86(2):158-64. doi: 10.1016/0002-9343(89)90261-1.
9
Treatment of Raynaud's phenomenon with calcium channel blockers.用钙通道阻滞剂治疗雷诺现象。
Am J Med. 1985 Feb 22;78(2B):39-42. doi: 10.1016/0002-9343(85)90168-8.
10
Digital vascular response to topical glyceryl trinitrate, as measured by laser Doppler imaging, in primary Raynaud's phenomenon and systemic sclerosis.通过激光多普勒成像测量的原发性雷诺现象和系统性硬化症中局部应用硝酸甘油后的数字血管反应。
Rheumatology (Oxford). 2002 Mar;41(3):324-8. doi: 10.1093/rheumatology/41.3.324.
引用本文的文献
1
Use of nitroglycerin ointment to treat primary and secondary Raynaud's phenomenon: a systematic literature review.硝酸甘油软膏治疗原发性和继发性雷诺现象的系统文献回顾。
Rheumatol Int. 2018 Dec;38(12):2209-2216. doi: 10.1007/s00296-018-4119-9. Epub 2018 Aug 22.
2
Advances in the treatment of Raynaud's phenomenon.雷诺现象治疗的进展。
Vasc Health Risk Manag. 2010 Mar 24;6:167-77. doi: 10.2147/vhrm.s4551.
3
A controlled trial of the effect of topical glyceryl trinitrate on skin blood flow and skin elasticity in scleroderma.一项关于局部应用硝酸甘油对硬皮病患者皮肤血流及皮肤弹性影响的对照试验。
Ann Rheum Dis. 1994 Mar;53(3):212. doi: 10.1136/ard.53.3.212-a.
4
Is there counter-current exchange of drugs in limbs after percutaneous absorption?经皮吸收后，肢体中是否存在药物的逆流交换？
Clin Pharmacokinet. 1989 Sep;17(3):141-4. doi: 10.2165/00003088-198917030-00001.
5
Management of Raynaud's phenomenon. Focus on newer treatments.雷诺现象的管理。聚焦于新型治疗方法。
Drugs. 1989 May;37(5):700-12. doi: 10.2165/00003495-198937050-00005.
本文引用的文献
1
The 1982 revised criteria for the classification of systemic lupus erythematosus.1982年系统性红斑狼疮分类的修订标准。
Arthritis Rheum. 1982 Nov;25(11):1271-7. doi: 10.1002/art.1780251101.
2
Analysis of coronary responses to various doses of intracoronary nitroglycerin.
Circulation. 1982 Aug;66(2):321-7. doi: 10.1161/01.cir.66.2.321.
3
Difference in nitroglycerin dose-response in the venous and arterial beds.静脉床和动脉床中硝酸甘油剂量反应的差异。
Eur J Clin Pharmacol. 1980 Nov;18(6):455-60. doi: 10.1007/BF00874655.
4
Pharmacokinetic-hemodynamic studies of nitroglycerin ointment in congestive heart failure.硝酸甘油软膏在充血性心力衰竭中的药代动力学-血流动力学研究。
Am J Cardiol. 1980 Oct;46(4):670-6. doi: 10.1016/0002-9149(80)90519-6.
5
Topical glyceryl trinitrate as adjunctive treatment in Raynaud's disease.局部用硝酸甘油作为雷诺病的辅助治疗
Lancet. 1982 Jan 9;1(8263):76-7. doi: 10.1016/s0140-6736(82)90215-x.
6
A randomised double-blind trial of diltiazem in the treatment of Raynaud's phenomenon.地尔硫䓬治疗雷诺现象的随机双盲试验。
Ann Rheum Dis. 1985 Jan;44(1):30-3. doi: 10.1136/ard.44.1.30.
7
Evolution of primary Raynaud's phenomenon (Raynaud's disease) to connective tissue disease.原发性雷诺现象（雷诺病）向结缔组织病的演变。
Arthritis Rheum. 1985 Jan;28(1):87-92. doi: 10.1002/art.1780280114.
8
The clinical significance of Raynaud's syndrome.雷诺氏综合征的临床意义。
Surgery. 1976 Dec;80(6):756-64.
9
Raynaud phenomena and finger systolic pressure during cooling.冷却过程中的雷诺现象与手指收缩压。
Scand J Clin Lab Invest. 1978 Dec;38(8):765-70. doi: 10.1080/00365517809104885.
10
Prevalence of primary Raynaud phenomena in young females.年轻女性原发性雷诺现象的患病率。
Scand J Clin Lab Invest. 1978 Dec;38(8):761-4. doi: 10.1080/00365517809104884.
Zotero 插件